Bert F. Bernard

4.2k total citations
64 papers, 3.4k citations indexed

About

Bert F. Bernard is a scholar working on Epidemiology, Radiology, Nuclear Medicine and Imaging and Oncology. According to data from OpenAlex, Bert F. Bernard has authored 64 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Epidemiology, 38 papers in Radiology, Nuclear Medicine and Imaging and 26 papers in Oncology. Recurrent topics in Bert F. Bernard's work include Neuroendocrine Tumor Research Advances (41 papers), Radiopharmaceutical Chemistry and Applications (37 papers) and Lung Cancer Research Studies (23 papers). Bert F. Bernard is often cited by papers focused on Neuroendocrine Tumor Research Advances (41 papers), Radiopharmaceutical Chemistry and Applications (37 papers) and Lung Cancer Research Studies (23 papers). Bert F. Bernard collaborates with scholars based in Netherlands, United States and Switzerland. Bert F. Bernard's co-authors include Eric P. Krenning, Marion de Jong, Marion de Jong, Wout A. P. Breeman, Theo J. Visser, Willem H. Bakker, E. P. Krenning, Edgar J. Rolleman, Helmut R. Mäcke and G Hennemann and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, FEBS Letters and Endocrinology.

In The Last Decade

Bert F. Bernard

64 papers receiving 3.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Bert F. Bernard Netherlands	35	1.8k	1.7k	1.4k	771	468	64	3.4k
Marion de Jong Netherlands	33	1.7k 0.9×	1.7k 1.0×	1.7k 1.2×	780 1.0×	559 1.2×	75	3.6k
Flavio Forrer Switzerland	27	1.4k 0.8×	1.3k 0.8×	1.2k 0.8×	634 0.8×	485 1.0×	51	2.9k
Stanislas Pauwels Belgium	29	1.3k 0.7×	2.1k 1.2×	1.8k 1.2×	1.2k 1.6×	427 0.9×	76	3.5k
Damian Wild Switzerland	36	1.7k 0.9×	2.9k 1.7×	2.6k 1.8×	1.5k 1.9×	468 1.0×	127	4.6k
Irina Velikyan Sweden	25	1.5k 0.9×	681 0.4×	990 0.7×	276 0.4×	423 0.9×	78	2.5k
Ananth Srinivasan United States	28	1.2k 0.6×	964 0.6×	885 0.6×	453 0.6×	284 0.6×	56	2.5k
E. P. Krenning Netherlands	24	483 0.3×	865 0.5×	629 0.4×	546 0.7×	194 0.4×	44	2.0k
Willem H. Bakker Netherlands	43	3.0k 1.7×	5.5k 3.3×	4.3k 3.0×	3.6k 4.6×	1.0k 2.2×	83	8.1k
Luc Mortelmans Belgium	37	2.0k 1.1×	540 0.3×	471 0.3×	326 0.4×	1.0k 2.2×	129	4.3k
Wolfgang Becker Germany	23	819 0.5×	458 0.3×	527 0.4×	104 0.1×	208 0.4×	38	1.6k

Countries citing papers authored by Bert F. Bernard

Since Specialization

Citations

This map shows the geographic impact of Bert F. Bernard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bert F. Bernard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bert F. Bernard more than expected).

Fields of papers citing papers by Bert F. Bernard

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bert F. Bernard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bert F. Bernard. The network helps show where Bert F. Bernard may publish in the future.

Co-authorship network of co-authors of Bert F. Bernard

This figure shows the co-authorship network connecting the top 25 collaborators of Bert F. Bernard. A scholar is included among the top collaborators of Bert F. Bernard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bert F. Bernard. Bert F. Bernard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bernard, Bert F., Wout A. P. Breeman, Flavio Forrer, et al.. (2008). Molecular imaging of reduced renal uptake of radiolabelled [DOTA0,Tyr3]octreotate by the combination of lysine and Gelofusine in rats. Nuklearmedizin - NuclearMedicine. 47(3). 110–115. 40 indexed citations

Forrer, Flavio, Edgar J. Rolleman, Marleen Melis, et al.. (2007). From Outside to Inside? Dose-Dependent Renal Tubular Damage After High-Dose Peptide Receptor Radionuclide Therapy in Rats Measured with In Vivo ^99m Tc-DMSA-SPECT and Molecular Imaging. Cancer Biotherapy and Radiopharmaceuticals. 22(1). 40–49. 26 indexed citations

Bernard, Bert F., Ananth Srinivasan, Jack L. Erion, et al.. (2007). Five Stabilized ¹¹¹ In-Labeled Neurotensin Analogs in Nude Mice Bearing HT29 Tumors. Cancer Biotherapy and Radiopharmaceuticals. 22(3). 374–382. 4 indexed citations

Müller, Cristina, Flavio Forrer, Bert F. Bernard, et al.. (2007). Diagnostic Versus Therapeutic Doses of [ ¹⁷⁷ Lu-DOTA-Tyr ³ ]-Octreotate: Uptake and Dosimetry in Somatostatin Receptor-Positive Tumors and Normal Organs. Cancer Biotherapy and Radiopharmaceuticals. 22(1). 151–159. 13 indexed citations

Breeman, Wouter A.P., Marion de Jong, Erik de Blois, et al.. (2005). Radiolabelling DOTA-peptides with 68Ga. European Journal of Nuclear Medicine and Molecular Imaging. 32(4). 478–485. 230 indexed citations

Capello, Astrid, Eric P. Krenning, Bert F. Bernard, et al.. (2005). 111In-labelled somatostatin analogues in a rat tumour model: somatostatin receptor status and effects of peptide receptor radionuclide therapy. European Journal of Nuclear Medicine and Molecular Imaging. 32(11). 1288–1295. 40 indexed citations

Capello, Astrid, Bert F. Bernard, Mark Konijnenberg, et al.. (2004). Low-Dose-Rate Irradiation by ¹³¹ I Versus High-Dose-Rate External-Beam Irradiation in the Rat Pancreatic Tumor Cell Line CA20948. Cancer Biotherapy and Radiopharmaceuticals. 19(3). 285–292. 12 indexed citations

Bernard, Bert F., Astrid Capello, Martin van Hagen, et al.. (2004). Radiolabeled RGD-DTPA-Tyr ³ -Octreotate for Receptor-Targeted Radionuclide Therapy. Cancer Biotherapy and Radiopharmaceuticals. 19(2). 173–180. 29 indexed citations

Breeman, Wouter A.P., et al.. (2004). Reduction of skeletal accumulation of radioactivity by co-injection of DTPA in [90Y-DOTA0,Tyr3]octreotide solutions containing free 90Y3+. Nuclear Medicine and Biology. 31(6). 821–824. 12 indexed citations

10.

Wild, Damian, Jörg Schmitt, Mihaela Ginj, et al.. (2003). DOTA-NOC, a high-affinity ligand of somatostatin receptor subtypes 2, 3 and 5 for labelling with various radiometals. European Journal of Nuclear Medicine and Molecular Imaging. 30(10). 1338–1347. 230 indexed citations

11.

Breeman, Wouter A.P., Amir Mearadji, Astrid Capello, et al.. (2003). Anti‐tumor effect and increased survival after treatment with [¹⁷⁷Lu‐DOTA⁰,Tyr³]octreotate in a rat liver micrometastases model. International Journal of Cancer. 104(3). 376–379. 29 indexed citations

12.

Capello, Astrid, Eric P. Krenning, Wout A. P. Breeman, et al.. (2003). Tyr ³ -Octreotide and Tyr ³ -Octreotate Radiolabeled with ¹⁷⁷ Lu or ⁹⁰ Y: Peptide Receptor Radionuclide Therapy Results In Vitro. Cancer Biotherapy and Radiopharmaceuticals. 18(5). 761–768. 23 indexed citations

13.

Wamel, Annemieke van, Ayache Bouakaz, Bert F. Bernard, Folkert J. ten Cate, & Nico de Jong. (2003). Radionuclide tumour therapy with ultrasound contrast microbubbles. Ultrasonics. 42(1-9). 903–906. 40 indexed citations

14.

Jong, Marion de, Wout A. P. Breeman, Bert F. Bernard, et al.. (1999). Tumour uptake of the radiolabelled somatostatin analogue [DOTA 0 ,TYR 3 ]octreotide is dependent on the peptide amount. European Journal of Nuclear Medicine and Molecular Imaging. 26(7). 693–698. 84 indexed citations

15.

Breeman, Wout A. P., Marion de Jong, Bert F. Bernard, et al.. (1999). Pre-clinical evaluation of [111In-DTPA-Pro1, Tyr4]bombesin, a new radioligand for bombesin-receptor scintigraphy. International Journal of Cancer. 83(5). 657–663. 69 indexed citations

16.

Bernard, Bert F., Eric P. Krenning, Wout A. P. Breeman, et al.. (1998). 99mTc-MIBI, 99mTc-Tetrofosmin and 99mTc-Q12 In Vitro and In Vivo. Nuclear Medicine and Biology. 25(3). 233–240. 43 indexed citations

17.

Jong, Marion de, Bert F. Bernard, Elza de Bruin, et al.. (1998). Internalization of radiolabelled [DTPA0]octreotide and [DOTA0, Tyr3]octreotide. Nuclear Medicine Communications. 19(3). 283–288. 99 indexed citations

18.

Klootwijk, W, L. M. B. Vaessen, Bert F. Bernard, et al.. (1995). Production and Characterization of Monoclonal and Polyclonal Antibodies against Thyrotropin-Releasing Hormone. Hybridoma. 14(3). 285–290. 14 indexed citations

19.

Jong, Marion de, Wout A. P. Breeman, Bert F. Bernard, et al.. (1995). Evaluation in vitro and in rats of161Tb-DTPA-octreotide, a somatostatin analogue with potential for intraoperative scanning and radiotherapy. European Journal of Nuclear Medicine and Molecular Imaging. 22(7). 608–616. 66 indexed citations

20.

Sadava, David, et al.. (1992). Development of Enzymes of Glycolysis and Gluconeogenesis in Human Fetal Liver. Neonatology. 62(2-3). 89–95. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact